FOR IMMEDIATE RELEASE

Introducing CureSight: A Game-Changing Lazy Eye Treatment Device

Kobi Kor introduces CureSight, a revolutionary lazy eye treatment device inspired by personal experience and designed to address the discomfort and social stigma associated with traditional treatment methods. The sleek, modern design integrates cutting-edge technologies for at-home treatment, marking a significant advancement in digital healthcare.

The CureSight device offers a powerful solution to transform the treatment of lazy eye conditions, leveraging high-end eye-tracking and AI software tools for personalized treatment. Unlike conventional patching methods, CureSight enables treatment while watching TV or streaming video content, enhancing comfort and compliance.

The design process involved extensive research and testing to ensure optimal usability and ergonomics. Utilizing aluminum CNC machining and anodized plating, as well as plastic injection, the device achieves a perfect balance of form and function.

Furthering its impact, the CureSight project commenced in 2019 in Tel Aviv and culminated in late 2021, with a notable showcase at CES in January 2020. The device's development was underpinned by rigorous research, culminating in a pivotal trial demonstrating its non-inferiority to traditional patching methods, with impressive adherence and parental preference.

Kobi Kor's dedication to creating a positive social impact through design is evident in the CureSight's emphasis on empowering and motivating young patients. The device's modern aesthetic draws inspiration from popular tech gadgets, ensuring a visually appealing and empowering treatment experience.

With a deep commitment to enhancing healthcare treatments, Kobi Kor's innovative approach has earned accolades, including the prestigious A' Design Award in 2022, recognizing CureSight's practicality, innovation, and positive contribution to the medical field.

-END-